BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 21 filers reported holding BIOPHARMX CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $59,000 | -59.0% | 671,686 | -50.0% | 0.00% | – |
| Q4 2018 | $144,000 | +13.4% | 1,343,372 | +100.0% | 0.00% | – |
| Q3 2018 | $127,000 | -14.2% | 671,686 | 0.0% | 0.00% | – |
| Q2 2018 | $148,000 | -4.5% | 671,686 | 0.0% | 0.00% | – |
| Q1 2018 | $155,000 | +342.9% | 671,686 | +107.3% | 0.00% | – |
| Q4 2017 | $35,000 | -62.0% | 323,967 | 0.0% | 0.00% | – |
| Q3 2017 | $92,000 | -40.6% | 323,967 | 0.0% | 0.00% | – |
| Q2 2017 | $155,000 | +1837.5% | 323,967 | +1775.5% | 0.00% | – |
| Q1 2017 | $8,000 | – | 17,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 12,814,286 | $6,471,000 | 1.90% |
| RTW INVESTMENTS, LP | 1,283,951 | $648,000 | 0.17% |
| Sio Capital Management, LLC | 313,717 | $158,000 | 0.09% |
| DAFNA Capital Management LLC | 115,000 | $58,000 | 0.05% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 28,027 | $14,000 | 0.00% |
| Baker Brothers Advisors | 377,295 | $191,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,994 | $55,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,499,615 | $4,797,000 | 0.00% |
| Moors & Cabot, Inc. | 13,000 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,274 | $8,000 | 0.00% |